StockData

Regal Rexnord vs Zebra Technologies

RRX and ZBRA side by side, both in general industrial machinery and equipment. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How RRX and ZBRA compare

Zebra Technologies is the larger company, worth 1.3 times as much as Regal Rexnord ($14.8B against $11.0B).

On earnings, Zebra Technologies is cheaper: it trades at 28.6× trailing earnings, against 34.0× for Regal Rexnord.

Zebra Technologies grew revenue faster over the last twelve months (12.7% versus 3.5% for Regal Rexnord).

Zebra Technologies keeps more of each dollar of sales as profit, with a net margin of 9.2% compared with 5.4% at Regal Rexnord.

Regal Rexnord pays a dividend yielding 0.85%; Zebra Technologies does not pay one.

Zebra Technologies scores higher on the StockData Score (12 against 9 for Regal Rexnord), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricRRXZBRA
Size and price
Market cap$11.0B$14.8B
Share price$164.94$312.21
Change, 1 year20.1%29.8%
Change, 5 years1.2%−47.1%
Beta (5Y)0.571.82
Employees29K11K
StockData Score
Total score912 (better)
Valuation score13 (better)
Growth score23 (better)
Performance score24 (better)
Health score12 (better)
Dividend score3 (better)0
Valuation
P/E34.0×28.6× (better)
P/S1.8× (better)2.5×
P/B1.6× (better)4.3×
EV/EBITDA21.5×16.2× (better)
P/FCF23.6×16.3× (better)
FCF yield4.2%6.1% (better)
Fair value$145.47$333.65
Margin of safety−13.4%6.4% (better)
Growth
Revenue growth (TTM)3.5%12.7% (better)
Revenue growth, 5Y average15.3% (better)3.9%
Net income growth (TTM)29.4% (better)−1.6%
EPS growth (TTM)29.0% (better)3.1%
EPS growth, 5Y average−1.8% (better)−2.6%
Profitability
Gross margin37.8%49.6% (better)
Operating margin11.7%14.7% (better)
Net margin5.4%9.2% (better)
FCF margin7.7%15.5% (better)
Return on equity4.8%15.3% (better)
Return on invested capital5.2%11.9% (better)
Financial health
Debt / equity0.67 (better)0.81
Net debt / EBITDA5.902.44 (better)
Interest coverage2.1×–
Current ratio2.28 (better)0.52
Altman Z-score1.953.35 (better)
Piotroski F-score8 (better)4
Dividends and buybacks
Dividend yield0.85%–
Payout ratio28.7%–
Years of dividend growth0–
Dividend growth, 5Y average3.1%–
Buyback yield–6.1%
Shareholder yield0.85%6.1% (better)
Ownership
Held by institutions108%104%
Held by insiders0.56%1.0%
Insider net buying, 12 months−$22.4M−$2.3M (better)
Superinvestors holding1–
Short interest, % of float3.8%2.8%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.